サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1105572

末期腎不全の世界市場規模調査：治療別（移植、透析）、エンドユーザー別（研究・学術機関、病院・クリニック、透析センター）、地域別予測（2022年～2028年）

Global End Stage Renal Disease Market Size study, By Treatment (Transplant, Dialysis), By End-User (Research and academic institutes, Hospital and Clinics, Dialysis centers), and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
末期腎不全の世界市場規模調査：治療別（移植、透析）、エンドユーザー別（研究・学術機関、病院・クリニック、透析センター）、地域別予測（2022年～2028年）
出版日: 2022年07月04日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

糖尿病や高血圧の増加、慢性腎臓病を患う患者数の増加、技術的に高度な製品の出現は、末期腎不全市場の成長を促進している主な要因となっています。

しかし、透析製品に対する厳しい規制政策、合併症のリスクが高いことが、市場成長を抑制しています。

当レポートでは、世界の末期腎不全市場について調査分析し、市場力学、業界分析、市場分析、競合情報など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の末期腎不全市場の定義と範囲

第3章 世界の末期腎不全市場力学

  • 末期腎不全市場への影響分析（2020年～2028年）

第4章 世界の末期腎不全市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 最高の投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-COVID-19以後の市場シナリオ

第6章 世界の末期腎不全市場：治療別

  • 市場スナップショット
  • 世界の末期腎不全市場実績－潜在分析：治療別
  • 世界の末期腎不全市場の推定と予測（100万米ドル）（2018年～2028年）：治療別
  • 末期腎不全市場、サブセグメント分析
    • 移植
    • 透析

第7章 世界の末期腎不全市場：エンドユーザー別

  • 市場スナップショット
  • 世界の末期腎不全市場実績－潜在分析：エンドユーザー別
  • 世界の末期腎不全市場の推定と予測（100万米ドル）（2018年～2028年）：エンドユーザー別
  • 末期腎不全市場、サブセグメント分析
    • 研究・学術機関
    • 病院・クリニック
    • 透析センター

第8章 世界の末期腎不全市場、地域分析

  • 地域の市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Nipro Corp.
    • Fresenius Medical Care AG & Co. KGaA
    • Baxter International, Inc.
    • Medtronic Plc
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • Asahi Kasei Medical Co., Ltd.
    • Cantel Medical
    • Nikkiso Co., Ltd.
    • JMS Co. Ltd.

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global End Stage Renal Disease Market, report scope
  • TABLE 2. Global End Stage Renal Disease Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global End Stage Renal Disease Market estimates & forecasts by Treatment 2018-2028 (USD Million)
  • TABLE 4. Global End Stage Renal Disease Market estimates & forecasts by End-User 2018-2028 (USD Million)
  • TABLE 5. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 6. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. U.S. End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 17. U.S. End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. Canada End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 19. Canada End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. UK End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 22. UK End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. Germany End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 25. Germany End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. RoE End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 28. RoE End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. China End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 31. China End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. India End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 34. India End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. Japan End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 37. Japan End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. RoAPAC End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 40. RoAPAC End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. Brazil End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 43. Brazil End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Mexico End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 46. Mexico End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. RoLA End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 49. RoLA End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. Row End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 52. Row End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. List of secondary sources, used in the study of global End Stage Renal Disease Market
  • TABLE 55. List of primary sources, used in the study of global End Stage Renal Disease Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global End Stage Renal Disease Market, research methodology
  • FIG 2. Global End Stage Renal Disease Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global End Stage Renal Disease Market, key trends 2021
  • FIG 5. Global End Stage Renal Disease Market, growth prospects 2022-2028
  • FIG 6. Global End Stage Renal Disease Market, porters 5 force model
  • FIG 7. Global End Stage Renal Disease Market, pest analysis
  • FIG 8. Global End Stage Renal Disease Market, value chain analysis
  • FIG 9. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global End Stage Renal Disease Market, regional snapshot 2018 & 2028
  • FIG 15. North America End Stage Renal Disease Market 2018 & 2028 (USD Million)
  • FIG 16. Europe End Stage Renal Disease Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific End Stage Renal Disease market 2018 & 2028 (USD Million)
  • FIG 18. Latin America End Stage Renal Disease Market 2018 & 2028 (USD Million)
  • FIG 19. Global End Stage Renal Disease Market, company market share analysis (2021)
目次

Global End Stage Renal Disease Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. End-stage renal disease is also known as end-stage kidney disease or kidney failure. This is a chronic condition in which an individual ceases functioning permanently, which requires a regular course of long-term dialysis or a kidney transplant to sustain life. The growing incidences of diabetes and hypertension, the rising number of patients suffering from chronic kidney disease, coupled with the emergence of technologically advanced products are the primary factors propelling the market demand across the globe. For instance, according to the International Diabetic Federation (IDF), in 2019, nearly 463 million adults (20-79 years) were suffering from diabetes, and the amount is projected to rise and reach around 700 million by 2045. Thereby, the rising incidences of diabetes are exhibiting a positive influence on the global market growth. However, the imposition of stringent regulatory policies for dialysis products and the high risk of complications hinders the market growth over the forecast period of 2022-2028. Also, the rising regulatory support and increasing healthcare expenditure are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global End Stage Renal Disease Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia Pacific is the leading region across the world in terms of market share owing to the presence of well-established healthcare facilities and high prevalence of target diseases, coupled with the rising population. Whereas, Europe is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing healthcare spending, and rising government initiatives & awareness campaigns for CKD, would create lucrative growth prospects for the End Stage Renal Disease Market across the European region.

Major market players included in this report are:

Nipro Corp.

Fresenius Medical Care AG & Co. KGaA

Baxter International, Inc.

Medtronic Plc

B. Braun Melsungen AG

Becton, Dickinson and Company

Asahi Kasei Medical Co., Ltd.

Cantel Medical

Nikkiso Co., Ltd.

JMS Co. Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:

Transplant

Dialysis

By End-User:

Research and academic institutes

Hospital and Clinics

Dialysis centers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global End Stage Renal Disease Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. End Stage Renal Disease Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. End Stage Renal Disease Market, by Treatment, 2020-2028 (USD Million)
    • 1.2.3. End Stage Renal Disease Market, by End-User, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global End Stage Renal Disease Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global End Stage Renal Disease Market Dynamics

  • 3.1. End Stage Renal Disease Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing incidences of diabetes and hypertension
      • 3.1.1.2. Rising number of patients suffering from chronic kidney disease
      • 3.1.1.3. Emergence of technologically advanced products
    • 3.1.2. Market Challenges
      • 3.1.2.1. Imposition of stringent regulatory policies for dialysis products
      • 3.1.2.2. High risk of complications
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising regulatory support
      • 3.1.3.2. Increasing healthcare expenditure

Chapter 4. Global End Stage Renal Disease Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global End Stage Renal Disease Market, by Treatment

  • 6.1. Market Snapshot
  • 6.2. Global End Stage Renal Disease Market by Treatment, Performance - Potential Analysis
  • 6.3. Global End Stage Renal Disease Market Estimates & Forecasts by Treatment, 2018-2028 (USD Million)
  • 6.4. End Stage Renal Disease Market, Sub Segment Analysis
    • 6.4.1. Transplant
    • 6.4.2. Dialysis

Chapter 7. Global End Stage Renal Disease Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global End Stage Renal Disease Market by End-User, Performance - Potential Analysis
  • 7.3. Global End Stage Renal Disease Market Estimates & Forecasts by End-User, 2018-2028 (USD Million)
  • 7.4. End Stage Renal Disease Market, Sub Segment Analysis
    • 7.4.1. Research and academic institutes
    • 7.4.2. Hospital and Clinics
    • 7.4.3. Dialysis centers

Chapter 8. Global End Stage Renal Disease Market, Regional Analysis

  • 8.1. End Stage Renal Disease Market, Regional Market Snapshot
  • 8.2. North America End Stage Renal Disease Market
    • 8.2.1. U.S. End Stage Renal Disease Market
      • 8.2.1.1. Treatment breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. End-User breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada End Stage Renal Disease Market
  • 8.3. Europe End Stage Renal Disease Market Snapshot
    • 8.3.1. U.K. End Stage Renal Disease Market
    • 8.3.2. Germany End Stage Renal Disease Market
    • 8.3.3. France End Stage Renal Disease Market
    • 8.3.4. Spain End Stage Renal Disease Market
    • 8.3.5. Italy End Stage Renal Disease Market
    • 8.3.6. Rest of Europe End Stage Renal Disease Market
  • 8.4. Asia-Pacific End Stage Renal Disease Market Snapshot
    • 8.4.1. China End Stage Renal Disease Market
    • 8.4.2. India End Stage Renal Disease Market
    • 8.4.3. Japan End Stage Renal Disease Market
    • 8.4.4. Australia End Stage Renal Disease Market
    • 8.4.5. South Korea End Stage Renal Disease Market
    • 8.4.6. Rest of Asia Pacific End Stage Renal Disease Market
  • 8.5. Latin America End Stage Renal Disease Market Snapshot
    • 8.5.1. Brazil End Stage Renal Disease Market
    • 8.5.2. Mexico End Stage Renal Disease Market
  • 8.6. Rest of The World End Stage Renal Disease Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Nipro Corp.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Fresenius Medical Care AG & Co. KGaA
    • 9.2.3. Baxter International, Inc.
    • 9.2.4. Medtronic Plc
    • 9.2.5. B. Braun Melsungen AG
    • 9.2.6. Becton, Dickinson and Company
    • 9.2.7. Asahi Kasei Medical Co., Ltd.
    • 9.2.8. Cantel Medical
    • 9.2.9. Nikkiso Co., Ltd.
    • 9.2.10. JMS Co. Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption